Per 0.5 mL Recombinant pertussis toxin 5 mcg, filamentous hemagglutinin 5 mcg
Indications/Uses
Active booster immunization against pertussis in individuals ≥11 yr. Alternative to combined tetanus, diphtheria & acellular pertussis vaccines in persons having received multiple & frequent tetanus & diphtheria vaccine doses.
View Pertagen overdosage for action to be taken in the event of an overdose.
Contraindications
Hypersensitivity or life-threatening reaction. Patients w/ encephalopathy w/ unknown aetiology eg, coma, prolonged seizures, or decreased level of consciousness w/in 7 days following previous vaccination w/ any whooping cough vaccine; progressive or unstable neurological disorders, uncontrolled epilepsy or progressive encephalopathy.
Not to be administered intravascularly or give fractional doses (<0.5 mL). Administration to patients who are suffering from acute severe febrile illness should be postponed. Patients who had any of the following adverse events w/in 48 hr after a previous immunization w/ any whooping cough vaccines: high temp (≥40ºC) w/o any identifiable cause, convulsions & collapse or shock-like state, patients w/ any bleeding disorders, thrombocytopenia or anticoagulant therapy.
Sign Out
